Prostate activity and prostate cancer in spinal cord injury

Prostate Cancer and Prostatic Diseases

Volumn 9, Issue 2, 2006, Pages 115-120

  Shim, H B ^a   Jung, T Y ^a   Lee, J K ^a   Ku, J H ^a  

^a Seoul Veterans Hospital   (South Korea)

Author keywords

Prostate; Prostate cancer; Prostate specific antigen; Spinal cord injury

Indexed keywords

ANDROGEN; PROSTATE SPECIFIC ANTIGEN;

AUTONOMIC NERVE; CARCINOGENESIS; CERVICAL SPINE; DENERVATION; HUMAN; INNERVATION; LUMBAR SPINE; MALE; NERVOUS SYSTEM INJURY; NONHUMAN; ORGAN SIZE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATE SECRETION; REVIEW; SPINAL CORD INJURY; THORACIC SPINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANDROGENS; ANIMALS; CASE-CONTROL STUDIES; DISEASE MODELS, ANIMAL; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INJURY SEVERITY SCORE; MALE; MIDDLE AGED; ORGAN SIZE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RATS; REFERENCE VALUES; RISK ASSESSMENT; SPINAL CORD INJURIES;

EID: 33745674479     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500865     Document Type: Review

References (39)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55: 10-30.
2. Spinal Cord Injury: Facts and Figures at a Glance. National Spinal Cord Injury Statistical Center: Birmingham, Alabama, 1994.
3. Vaalasti A, Hervonen A. Autonomic innervation of the human prostate. Invest Urol 1980; 17: 293-297.
4. Vaalasti A, Hervonen A. Innervation of the ventral prostate of the rat. Am J Anat 1979; 154: 231-243.
5. Farnsworth WE, Lawrence MH. Regulation of prostate secretion in the rat. Proc Soc Exp Biop Med 1965; 119: 373-376.
6. Wang JM, McKenna KE, Lee C. Determination of prostatic secretion in rats: Effect of neurotransmitters and testosterone. Prostate 1991; 18: 289-301.
7. Martinez-Pineiro L, Dahiya R, Tanagho EA, Schmidt RA. Pelvic plexus denervation in rats causes morphologic and functional changes of the prostate. J Urol 1993; 150: 215-218.
8. Wang JM, McKenna KE, McVary KT, Lee C. Requirement of innervation for maintenance of structural and functional integrity in the rat prostate. Biol Reprod 1991; 44: 1171-1176.
9. Doggweiler R, Zermann DH, Ishigooka M, Schmidt RA. Botox-induced prostatic involution. Prostate 1998; 37: 44-50.
10. Linsenmeyer TA, Pogach LM, Ottenweller JE, Huang HF. Spermatogenesis and the pituitary-testicular hormone axis in rats during the acute phase of spinal cord injury. J Urol 1994; 152: 1302-1307.
11. Huang HF, Pogach LM, Nathan E, Giglio W, Seebode JJ. Synergistic effects of follicle-stimulating hormone and testosterone on the maintenance of spermiogenesis in hypophysectomized rats: Relationship with the androgen-binding protein status. Endocrinology 1991; 128: 3152-3161.
12. Huang HF, Li MT, Linsenmeyer TA, Ottenweller JE, Pogach LM, Irwin RJ. The effects of spinal cord injury on the status of messenger ribonucleic acid for TRPM 2 and androgen receptor in the prostate of the rat. J Androl 1997; 18: 250-256.
13. Benaim EA, Montoya JD, Saboorian MH, Litwiller S, Roehrborn CG. Characterization of prostate size, PSA and endocrine profiles in patients with spinal cord injuries. Prostate Cancer Prostatic Dis 1998; 1: 250-255.
14. Pannek J, Berges RR, Cubick G, Meindl R, Senge T. Prostate size and PSA serum levels in male patients with spinal cord injury. Urology 2003; 62: 845-848.
15. Frisbie JH, Kumar S, Aguilera EJ, Yalla S. Prostate atrophy and spinal cord lesions. Spinal Cord 2006; 44: 24-27.
16. Benaim EA, Saboorian H, Roehrborn CG, McConnell JD. The structure and intrinsic innervation of the prostate in patients with spinal cord injuries. J Urol 1998; 159 (Suppl 2): 106.
17. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474-479.
18. Lynne CM, Aballa TC, Wang TJ, Rittenhouse HG, Ferrell SM, Brackett NL. Serum and semen prostate specific antigen concentrations are different in young spinal cord injured men compared to normal controls. J Urol 1999; 162: 89-91.
19. Konety BR, Nguyen TT, Brenes G, Lewis N, Saul M, Nelson JB et al. Evaluation of the effect of spinal cord injury on serum PSA levels. Urology 2000; 56: 82-86.
20. Alexandrino AP, Rodrigues MA, Matsuo T. Evaluation of serum and seminal levels of prostate specific antigen in men with spinal cord injury. J Urol 2004; 171: 2230-2232.
21. Pramudji CK, Mutchnik SE, DeConcini D, Boone TB. Prostate cancer screening with prostate specific antigen in spinal cord injured men. J Urol 2002; 167: 1303-1305.
22. Hasui Y, Marutsuka K, Asada Y, Ide H, Nishi S, Osada Y. Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate 1994; 25: 91-96.
23. Abrahamsson PA, Lilja H, Oesterling JE. Molecular forms of serum prostate-specific antigen. The clinical value of percent free prostate-specific antigen. Urol Clin North Am 1997; 24: 353-365.
24. Brasso K, Sonksen J, Sommer P, Odum L, Biering-Sorensen F, Iversen P et al. Seminal plasma PSA in spinal cord injured men: A preliminary report. Spinal Cord 1998; 36: 771-773.
25. Ito TY, Mehta M. Adenocarcinoma of the prostate in paraplegics. Paraplegia 1976; 14: 101-104.
26. Bauman WA, Spungen AM. Metabolic changes in persons after spinal cord injury. Phys Med Rehabil Clin North Am 2000; 11: 109-140.
27. Huang TS, Wang YH, Lee SH, Lai JS. Impaired hypothalamus-pituitary-adrenal axis in men with spinal cord injuries. Am J Phy Med Rehabil 1998; 77: 108-112.
28. Federman Q, Tannenbaum M, Vereczkey Z. Reduced incidence risk of prostatic carcinoma in patients with spinal cord injury. Am J Paraplegia 1993; 16 (Suppl): 280.
29. Frisbie JH, Binard J. Low prevalence of prostatic cancer among myelopathy patients. J Am Paraplegia Soc 1994; 17: 148-149.
30. Frisbie JH. Cancer of the prostate in myelopathy patients: Lower risk with higher levels of paralysis. J Spinal Cord Med 2001; 24: 92-94.
31. Wyndaele JJ, Iwatsubo E, Perkash I, Stohrer M. Prostate cancer: A hazard also to be considered in the ageing male patient with spinal cord injury. Spinal Cord 1998; 36: 299-302.
32. Scott Sr PA, Perkash I, Mode D, Wolfe VA, Terris MK. Prostate cancer diagnosed in spinal cord-injured patients is more commonly advanced stage than in able-bodied patients. Urology 2004; 63: 509-512.
33. Safarinejad MR. Level of injury and hormone profiles in spinal cord-injured men. Urology 2001; 58: 671-676.
34. Bauman WA, Spungen AM, Adkins RH, Kemp BJ. Metabolic and endocrine changes in persons aging with spinal cord injury. Assist Technol 1999; 11: 88-96.
35. Wilson DW, Harper ME, Jensen HM, Ikeda RM, Richards G, Peeling WB et al. A prognostic index for the clinical management of patients with advanced prostatic cancer: A British Prostate Study Group investigation. Prostate 1985; 7: 131-141.
36. De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: Implications for prostatic carcinogenesis. Am J Pathol 1992; 155: 1985-1992.
37. Harper ME, Pierrepoint CG, Griffiths K. Carcinoma of the prostate: relationship of pretreatment hormone levels to survival. Eur J Cancer Clin Oncol 1984; 20: 477-482.
38. Ribeiro M, Ruff P, Falkson G. Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer. Am J Clin Oncol 1997; 20: 605-608.
39. Gammon SR, Berni KC, Virgo KS, Johnson FE. Surgical treatment for prostate cancer in patients with prior spinal cord injury. Ann Surg Oncol 2005; 12: 674-678.